Brief: Genmab Says Phase 1/2 Rainfol-01 Data Show Rina-S And Bevacizumab Combination Tolerable

Genmab A/S

13/04/2026 14:37

April 13 (Reuters) - Genmab A/S GMAB.CO:

REG-GENMAB PRESENTS THE SAFETY AND TOLERABILITY OF RINATABART SESUTECAN  (RINA-S®) IN COMBINATION WITH BEVACIZUMAB IN ADVANCED OVARIAN CANCER

PHASE 1/2 RAINFOL-01 DATA SHOW RINA-S AND BEVACIZUMAB COMBINATION TOLERABLE WITH NO NEW SAFETY SIGNALS

Source text: ID:nGNE9q3Z7q

Further company coverage: GMAB.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))